Noticias Institucionales

17 Jul 2019

Ana Janic received her PhD in 2011 after completing her her doctoral studies in Cayetano González’s Cell Division Laboratory.

The jury for the prize acknowledged the outstanding quality of Ana Janic’s contributions to science, and her seniority along her career.

29 May 2019

The new institution will represent and give visibility to young scientists, preferably from the field of experimental sciences

<p>IRB Barcelona’s Open Day</p>
24 May 2019

Personal chronicle of the day by Tanya Yates

Although the event itself is not due to start till 10 am, at 7 am a small group of sleepy people from the Communications Department (including me) are already busy with the logistics of the event. Bit by bit, our eager “crazies” (different generations of our Crazy About Biomedicine programme for secondary school students) start to arrive, PhD students turn up to organise the multiple stands in the Science Fair, admin staff take up duties at the registration desk… it’s 10 am. I love punctuality!

People start to trickle down the street. It’s...

22 May 2019

It is estimated that one in four people will require brain treatment at some point. While there are drug candidates for most diseases of the brain, the blood-brain barrier (BBB) poses an impassable obstacle for most of these compounds and a bottleneck for the delivery of drugs that could cure these patients.

In the Peptides and Proteins Lab at the Institute for Research in Biomedicine (IRB Barcelona), Dr. Meritxell Teixidó headsa line of research that, after 10 years, has led to the development of a technology called Gate2Brain. This patented technology consists of three...

<p>Clara Campàs, founding partner of Asabys Partners, Salvador Aznar-Benitah and Valerie Vanhooren, founders of Ona Therapeutics, and Sergio Pérez, director of Sabadell Venture Capital</p>
21 May 2019

Ona Therapeutics, a spin-off from IRB Barcelona and ICREA, has been founded by researchers Salvador Aznar-Benitah and Valerie Vanhooren after receiving investment from Sabadell Asabys.

Based at the Barcelona Science Park, the company focuses on the development of a new drug for the treatment of metastatic cancer.

The Sabadell Asabys Fund, which belongs to Asabys Partners, has invested € 1.5M into the company in order to start a venture round that could reach € 20M.

<p>Francesc Posas, director of IRB Barcelona.</p>
2 May 2019

Academia Programme run by ICREA seeks to foster research excellence among professors at public universities in Catalonia.

<p>Press conference at IRB Barcelona, presenting the #MetastasisChallenge</p>
19 Mar 2019

Through the campaign called #MetastasisChallenge, the centre aims to raise €5 M over the next four years.

Metastasis is responsible for 90% of deaths from cancer, and this campaign aims to rally social support for research in order to speed up discoveries.

<p>Starlife’s presentation at the Barcelona Supercomputing Center</p>
27 Feb 2019

It’s a joint initiative of IRB Barcelona, the Barcelona Supercomputing Center and the Centre for Genomic Regulation.

“StarLife” is funded by the Catalan Government, through the European Regional Development Fund, and by ”la Caixa”.

<p>Gloria Pascual, Research Associate at IRB Barcelona. Picture: Fundación Pfizer</p>
19 Feb 2019

The Pfizer Foundation has awarded the IRB Barcelona scientist a prize within the “Basic Research” category.

Gloria Pascual, a member of the Stem Cells and Cancer lab, will receive €10,000 to continue her research

<p>"Art Made of Science – Microspheres". Source: Quo Artis</p>
5 Feb 2019

From 12/02 to 12/03, the Artist in Residence, Ayse Güll Süter, will be exhibiting her work: “Art made of Science-Microspheres” at the Sant Pau Art Nouveau Site (Recinto Modernista de Sant Pau).

This project has been done in collaboration with the Fundación Quo Artis, the Sant Pau Art Nouveau Site, and IRB Barcelona.